Recognized as China's first generic equivalent.
Included in the National Reimbursement Drug List (NRDL) and the National Essential Drugs List (NEDL).
Successful winning bid in the National Volume-Based Procurement (VBP).
Ranked No.1 in domestic market share for brand-name products.
2013 Chinese Guidelines for the Diagnosis and Treatment of Chronic Constipation